Barinthus Biotherapeutics
Barinthus Biotherapeutics Logo
About Barinthus Biotherapeutics
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on the discovery and development of novel T cell immunotherapeutics and vaccines. Its pipeline includes candidates for chronic infectious diseases, autoimmunity, and cancer, such as VTP-300 for chronic hepatitis B, VTP-200 for HPV infection, and VTP-1000 for celiac disease. The company also develops prophylactic vaccines and collaborates with global partners. Barinthus Biotherapeutics aims to guide the immune system to overcome disease and improve patient outcomes.
Address
Zeus Building, Unit 6-10 Rutherford Avenue Harwell
Didcot, OX11 0DF
United Kingdom
Year founded
2021
Number of employees
100-200
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
